POD-11.01: Dose Finding and Safety Analysis of Inecalcitol in Combination with Docetaxel-Prednisone Regimen in Hormone-Refractory Prostate Cancer (HRPC) Patients (PTS)
2009; Elsevier BV; Volume: 74; Issue: 4 Linguagem: Inglês
10.1016/j.urology.2009.07.1099
ISSN1527-9995
AutoresJ. Medioni, G. Deplanque, Tristan Maurina, J-M Ferrero, Jean-Michel Rodier, Éric Raymond, J. Allyon, S. Kalla, J. Dufour-Lamartinie, Stéphane Oudard,
Tópico(s)Pharmacological Effects and Toxicity Studies
ResumoInecalcitol is a novel synthetic vitamin D3 analogue with potent antiproliferative effects in human cancer cell lines and a 100-fold lower hypercalcemic activity than calcitriol in animal models.
Referência(s)